Clinical trial
Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC).
NCT02831959
Study timeline
Study start (unknown)2016-07-01Date precision: month
Registry last updated2025-10-31
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Interventions
NovoTTF-200M deviceDEVICE
Sponsors & collaborators
NovoCure GmbHlead sponsor
Mapped research locations
MontrealQuebec, Canada3MinneapolisMinnesota, United States3JacksonvilleFlorida, United States3HoustonTexas, United States2BostonMassachusetts, United States2BirminghamAlabama, United States2PhoenixArizona, United States2OrlandoFlorida, United States2SacramentoCalifornia, United States2SofiaBulgaria2WuhanHubei, China2JinanShandong, China2
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02831959 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.